Six million Americans have type 1 and other insulin dependent diabetes.
That’s over six million people to stand together against inflated drug prices, discrimination in access to health care and insurance (including inflated cost sharing), discrimination in school or employment. T1DF was created to safeguard and, if necessary, fight for your rights. But we can't do it without your help.
Our civil rights and consumer protection programs depend on people like you who are willing to take action.
Americans with diabetes are not alone in this fight. People with congenital hyperinsulinism and anaphylaxis currently face similar discrimination and financial barriers in accessing life-saving treatments including glucagon and EpiPen.
Not interested in being a plaintiff? We still hope you'll share your concerns and your support.
The Type 1 Diabetes Defense Foundation is a nonpartisan Oregon-based 501(c)(3) nonprofit dedicated to advancing equal rights and opportunities for Americans with type 1 and other forms of insulin dependent diabetes. T1DF accepts no funding from the pharmaceutical, medical device, pharmacy benefit management, or insurance industries or from any organization they fund. We support regulatory frameworks in which manufacturers compete directly on innovation and price to consumers and where drug channel actors can engage in open and efficient price arbitraging, without price discrimination and asymmetries of information.